Home
Conditions
Stage IV Pancreatic Cancer AJCC v8

Clinical trial condition

Stage IV Pancreatic Cancer AJCC v8

Explore clinical trials studying Stage IV Pancreatic Cancer AJCC v8. Study availability and eligibility vary by location and protocol.

50 public trials 17 recruiting studies

Refine in advanced search Browse all conditions

Stage IV Pancreatic Cancer AJCC v8 trial results

Recruiting

OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma

NCT07089940

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
Locations: OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Recruiting

Targeted Pathway Inhibition in Patients With Pancreatic Cancer

NCT04005690

Conditions: Borderline Resectable Pancreatic Ductal Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +13 more
Locations: OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Recruiting

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

NCT06906562

Conditions: Advanced Pancreatic Carcinoma, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: Ohio State University-Telemedicine Birmingham, Alabama, United States

Ohio State University-Telemedicine Mobile, Alabama, United States

Ohio State University Telemedicine Montgomery, Alabama, United States

Ohio State University-Telemedicine Anchorage, Alaska, United States

View all 109 locations

View Trial Details

Recruiting

Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer

NCT04115163

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Recruiting

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

NCT06073431

Conditions: Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Pancreatic Adenocarcinoma, +26 more
Locations: Mercy Hospital Fort Smith Fort Smith, Arkansas, United States

Rocky Mountain Cancer Centers-Aurora Aurora, Colorado, United States

Boulder Community Foothills Hospital Boulder, Colorado, United States

Rocky Mountain Cancer Centers-Boulder Boulder, Colorado, United States

View all 225 locations

View Trial Details

Recruiting

Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis

NCT04858009

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors

NCT05733000

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adnexal Diseases, +67 more
Locations: Northwestern University Chicago, Illinois, United States

View Trial Details

Not Yet Recruiting

Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a, for Advanced Pancreatic Ductal Adenocarcinoma

NCT07619521

Conditions: Advanced Pancreatic Ductal Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer

NCT07619313

Conditions: Adenocarcinoma, Borderline Resectable Pancreatic Ductal Adenocarcinoma, Carcinoma, +18 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Not Yet Recruiting

64Cu-DOTA A2 scFv-Fc2 DM With Positron Emission Tomography for the Imaging of Patients With Locally Advanced or Metastatic PSCA-Expressing Pancreatic Cancer

NCT07608627

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +9 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Stage IV Pancreatic Cancer AJCC v8

Stage IV Pancreatic Cancer AJCC v8 trial results

Related conditions